Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ZEISS Acquires Xradia

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
X-ray microscopy solutions close the gap between light and electron microscopy.

The closing took place on July 12, 2013 after all formal conditions, as set in the Acquisition Agreement, were fulfilled. Xradia, Inc. is now operating under the new name of Carl Zeiss X-ray Microscopy, Inc. This acquisition further strengthens the position of the ZEISS Microscopy business group, the only manufacturer of light, electron and X-ray microscopes, with unique solutions for research and routine inspection in materials and life sciences application fields.

X-ray microscopes show unique capabilities in materials research, allowing for 3D imaging of the internal structure of materials. Spatial resolution down to 50 nanometers can be achieved on a laboratory-based system. The non-destructive nature of X-ray imaging enables the observation and quantification of microstructural evolution in the same region of a single sample over time, or under changing environmental conditions. Several examples of in situ and 4D (three-dimensional imaging over time) experiments are proving beneficial for research and industry, including crack propagation in ceramics and metals, porosity and permeability characterization of geological and functional materials, failure analysis of structural materials, biomechanical systems under load, and the evolution of defects in operating lithium ion batteries and fuel cells.

X-ray microscopes close the resolution gap between light and electron microscopy and offer scientists multiple new imaging modalities to complement their research. The unique optical design allows the ZEISS Xradia Ultra and Versa series to cover a large resolution range, enabling the user to easily find the region of interest by zooming into larger samples (Scout-and-Zoom). ZEISS is working towards integrated workflow solutions for life sciences and materials research. In materials science, this is typically achieved by using X-ray microscopes to perform non-destructive 4D microstructural evolution experiments prior to destructive sectioning and then using electron microscope techniques for additional resolution and contrast. In life sciences, X-ray microscopes are being used to provide a navigational map of the subsurface after tissue samples have been stained for electron microscope investigation. By incorporating 3D X-ray microscopes into this workflow, the emerging 3D electron microscope techniques will gain a significant boost in efficiency.

While maintaining close customer relationships and continuing with current projects, ZEISS is leveraging its vast sales force to make the X-ray technology more accessible in a broader range of applications and workflows. Customers will also benefit from direct service capabilities at multiple locations globally.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bessel Beam Plane Illumination Microscopy Enables Fast 3D Volume Imaging
ZEISS and the Janelia Research Campus sign an exclusive license agreement for commercialization.
Tuesday, September 16, 2014
Scientific News
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!